Drug
Govorestat
Govorestat: highest development phase Phase 3, developed by Applied Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Applied Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Govorestat NCT07191912 | Phase 3 | Charcot-Marie-Tooth Disease With Sorbitol Dehydrogenase Deficiency (CMT-SORD) |
Latest
No recent events.
Follow Govorestat on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.